Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01968525
Other study ID # 199987
Secondary ID
Status Completed
Phase N/A
First received October 12, 2013
Last updated October 18, 2013
Start date April 2013
Est. completion date September 2013

Study information

Verified date October 2013
Source Fudan University
Contact n/a
Is FDA regulated No
Health authority China: Ministry of HealthUnited States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

1. Every individual receiving a general anesthetic is at potential risk for developing a ''cannot intubate-cannot ventilate'' situation following anesthetic induction.

2. Building up of oxygen reserves assumes great significance as this provides a longer duration of non-hypoxic apnea should one be faced with an unanticipated difficult airway.

3. The main physiological functions of red blood cell hemoglobin are to deliver oxygen to the peripheral tissues.

4. During anemia, a reduction in blood oxygen content occurs as a result of reduced Hb while arterial oxygenation and oxyhemoglobin saturation remain high.

5. Previous studies about the duration of non-hypoxic apnoea focus on methods to improve the safety period of tracheal intubation.

6. To our knowledge, there is no literature about the duration of non-hypoxic apnoea of anemia patients.

7. The aim of this study was to assess the effect of chronic anemia on the duration of non-hypoxic apnoea during induction of anaesthesia.


Description:

After breathing for 3 minutes, anesthesia induction was conducted. The endotracheal tube position was confirmed after anesthesia induction. Patients were left apneic with the endotracheal tube open to room air. The non-hypoxic apneic period was recorded as the time (in seconds) taken for the drop in pulse saturation to 90% or an apneic period of 10 min elapsed, whichever was earlier.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date September 2013
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

1. patients scheduled to undergo general anesthesia

2. American Society of Anesthesiologists Performance Status 1-2

3. adults

Exclusion Criteria:

1. Individuals with significant cardiorespiratory or cerebrovascular disease,

2. difficult intubation

3. history of epilepsy

4. body mass index >25 kg/m2,

5. and those who had smoking history in past 6 months

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Biological:
pre-oxygen
3 min of preoxygenation before anesthesia induction.

Locations

Country Name City State
China Fudan university Shanghai Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Fudan University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary duration of non-hypoxic apnoea up to 6 months Yes
See also
  Status Clinical Trial Phase
Completed NCT00631163 - Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis Phase 2
Completed NCT03802201 - Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia Phase 2